CIK 0000711377
- Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 382367843
- Phone
- +1 517-372-9200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-07 | Jones Douglas Edward Chief Operating Officer | Shares withheld for taxes | −3,766 | $15.07 | $57K | 59,612 |
| 2024-10-07 | Jones Douglas Edward Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −12,939 | $15.07 | $195K | 12,940 |
| 2024-10-07 | ADENT JOHN EDWARD CEO | Exercise or conversion | +32,937 | $15.07 | $496K | 211,563 |
| 2024-10-07 | ADENT JOHN EDWARD CEO | Shares withheld for taxes | −9,586 | $15.07 | $144K | 201,977 |
| 2024-10-07 | ADENT JOHN EDWARD CEO | Exercise or conversion · Restricted Stock Units | −32,937 | $15.07 | $496K | 32,936 |
| 2024-10-07 | Gupta Aashima Director | Exercise or conversion | +2,070 | $15.07 | $31K | 4,141 |
| 2024-10-07 | Gupta Aashima Director | Exercise or conversion · Restricted Stock Units | −2,070 | $15.07 | $31K | 2,071 |
| 2024-10-07 | CAPELLO JEFFREY D Director | Exercise or conversion | +2,070 | $15.07 | $31K | 4,141 |
| 2024-10-07 | CAPELLO JEFFREY D Director | Exercise or conversion · Restricted Stock Units | −2,070 | $15.07 | $31K | 2,071 |
| 2024-10-07 | Woteki Catherine E Director | Exercise or conversion | +2,070 | $15.07 | $31K | 5,462 |
| 2024-10-07 | Woteki Catherine E Director | Exercise or conversion | +236 | $14.89 | $4K | 5,698 |
| 2024-10-07 | Woteki Catherine E Director | Exercise or conversion · Restricted Stock Units | −2,070 | $15.07 | $31K | 2,071 |
| 2024-10-07 | Woteki Catherine E Director | Exercise or conversion · Restricted Stock Units | −236 | $14.89 | $4K | 0 |
| 2024-10-07 | Tobin James P Director | Exercise or conversion | +2,070 | $15.07 | $31K | 25,462 |
| 2024-10-07 | Tobin James P Director | Exercise or conversion | +236 | $14.89 | $4K | 25,698 |
| 2024-10-07 | Tobin James P Director | Exercise or conversion · Restricted Stock Units | −2,070 | $15.07 | $31K | 2,071 |
| 2024-10-07 | Tobin James P Director | Exercise or conversion · Restricted Stock Units | −236 | $14.89 | $4K | 0 |
| 2024-10-07 | RODRIGUEZ RAFAEL A Director | Exercise or conversion | +2,070 | $15.07 | $31K | 5,462 |
| 2024-10-07 | RODRIGUEZ RAFAEL A Director | Exercise or conversion | +236 | $14.89 | $4K | 5,698 |
| 2024-10-07 | RODRIGUEZ RAFAEL A Director | Exercise or conversion · Restricted Stock Units | −2,070 | $15.07 | $31K | 2,071 |
Page 15 of 21 · 414 trades